The consideration of synthetic short interfering RNA for therapeutic use

Basic and Clinical Pharmacology and Toxicology

Volumn 106, Issue 1, 2010, Pages 22-29

  Li, Jun ^a   Liang, Zicai ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BUTANEDIOL DIGLYCIDYL ETHER; ALPHA TOCOPHEROL; ARGININE DERIVATIVE; ARGINYLGLYCYLASPARTIC ACID; CARDIOLIPIN; CHITOSAN; CHOLESTEROL; CHOLESTERYLOLIGO DEXTRO ARGININE; CYCLODEXTRIN; DENDRIMER; DIOLEOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; ETHER DERIVATIVE; GLYCOPROTEIN GP 41; HEPTAPEPTIDE; HYALURONIC ACID; LACTOSE; LIPOSOME; MACROGOL; NANOPARTICLE; PENETRATIN; POLOXAMER; POLYAMIDOAMINE; POLYETHYLENEIMINE DERIVATIVE; POLYLYSINE; SMALL INTERFERING RNA; TRANSPORTAN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS LARGE T ANTIGEN;

DISULFIDE BOND; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DEGRADATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PENETRATION; DRUG STABILITY; GLOMERULUS FILTRATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RNA INTERFERENCE; SHORT SURVEY;

ANIMALS; HUMANS; KIDNEY GLOMERULUS; LIPOSOMES; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION;

EID: 73649111445     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00464.x     Document Type: Short Survey

References (75)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998 391 : 806 811. (Pubitemid 28099681)
2. DeVincenzo J, Cehelsky JE, Alvarez R, Elbashir S, Harborth J, Toudjarska I et al. Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV). Antiviral Res 2008 77 : 225 231.
3. Aigner A. Nonviral in vivo delivery of therapeutic small interfering RNAs. Curr Opin Mol Ther 2007 9 : 345 352.
4. Braasch DA, Paroo Z, Constantinescu A, Ren G, Oz OK, Mason RP et al. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett 2004 14 : 1139 1143.
5. Beverly M, Hartsough K, Machemer L. Liquid chromatography/electrospray mass spectrometric analysis of metabolites from an inhibitory RNA duplex. Rapid Commun Mass Spectrom 2005 19 : 1675 1682.
6. Paroo Z, Corey DR. Challenges for RNAi in vivo. Trends Biotechnol 2004 22 : 390 394.
7. Haupenthal J, Baehr C, Kiermayer S, Zeuzem S, Piiper A. Inhibition of RNAse A family enzymes prevents degradation and loss of silencing activity of siRNAs in serum. Biochem Pharmacol 2006 71 : 702 710.
8. Corey DR. Chemical modification: the key to clinical application of RNA interference? J Clin Invest 2007 117 : 3615 3622.
9. Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA et al. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 2003 42 : 7967 7975.
10. Choung S, Kim YJ, Kim S, Park HO, Choi YC. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun 2006 342 : 919 927.
11. Akita H, Harashima H. Nonviral gene delivery. Contrib Nephrol 2008 159 : 13 29.
12. van de Water FM, Boerman OC, Wouterse AC, Peters JG, Russel FG, Masereeuw R. Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos 2006 34 : 1393 1397.
13. Viel T, Boisgard R, Kuhnast B, Jego B, Siquier-Pernet K, Hinnen F et al. Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs). Oligonucleotides 2008 18 : 201 212.
14. Moschos SA, Jones SW, Perry MM, Williams AE, Erjefalt JS, Turner JJ et al. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug Chem 2007 18 : 1450 1459.
15. Muratovska A, Eccles MR. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett 2004 558 : 63 8.
16. Nishina K, Unno T, Uno Y, Kubodera T, Kanouchi T, Mizusawa H et al. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol Ther 2008 16 : 734 740.
17. Jing Y, Shishkov A, Ponnappa BC. Inhibition of tumor necrosis factor alpha secretion in rat Kupffer cells by siRNA: in vivo efficacy of siRNA-liposomes. Biochim Biophys Acta 2008 1780 : 34 40.
18. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003 327 : 761 766. (Pubitemid 36315917)
19. Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum 2006 54 : 1867 1877.
20. Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN et al. RNAi-mediated gene silencing in non-human primates. Nature 2006 441 : 111 114.
21. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Fisch G et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther 2006 13 : 1222 1234.
22. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B et al. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther 2006 13 : 1360 1370.
23. Kim JY, Choung S, Lee EJ, Kim YJ, Choi YC. Immune activation by siRNA/liposome complexes in mice is sequence-independent: lack of a role for Toll-like receptor 3 signaling. Mol Cells 2007 24 : 247 254.
24. Chien PY, Wang J, Carbonaro D, Lei S, Miller B, Sheikh S et al. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther 2005 12 : 321 328.
25. Halder J, Kamat AA, Landen CN Jr., Han LY, Lutgendorf SK, Lin YG et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006 12 : 4916 4924.
26. Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, Han LY et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J Natl Cancer Inst 2008 100 : 359 372.
27. Mudhakir D, Akita H, Tan E, Harashima H. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway. J Control Release 2008 125 : 164 173.
28. Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008 26 : 431 442.
29. Kim WJ, Christensen LV, Jo S, Yockman JW, Jeong JH, Kim YH et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 2006 14 : 343 350.
30. Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007 448 : 39 43.
31. Sato A, Choi SW, Hirai M, Yamayoshi A, Moriyama R, Yamano T et al. Polymer brush-stabilized polyplex for a siRNA carrier with long circulatory half-life. J Control Release 2007 122 : 209 216.
32. Deshayes S, Morris M, Heitz F, Divita G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 2008 60 : 537 547.
33. Meade BR, Dowdy SF. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv Drug Deliv Rev 2008 60 : 530 536.
34. Meyer M, Philipp A, Oskuee R, Schmidt C, Wagner E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J Am Chem Soc 2008 130 : 3272 3273.
35. Bonnet ME, Erbacher P, Bolcato-Bellemin AL. Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm Res 2008 25 : 2972 2982.
36. Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005 12 : 461 466.
37. Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-DiCaprio K et al. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis 2006 193 : 1650 1657.
38. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release 2008 129 : 107 116.
39. Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc Natl Acad Sci U S A 2005 102 : 5679 5684.
40. Thomas M, Lu JJ, Chen J, Klibanov AM. Non-viral siRNA delivery to the lung. Adv Drug Deliv Rev 2007 59 : 124 133.
41. Kim WJ, Chang CW, Lee M, Kim SW. Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy. J Control Release 2007 118 : 357 363.
42. Jere D, Xu CX, Arote R, Yun CH, Cho MH, Cho CS. Poly(beta-amino ester) as a carrier for si/shRNA delivery in lung cancer cells. Biomaterials 2008 29 : 2535 2547.
43. Sutton D, Kim S, Shuai X, Leskov K, Marques JT, Williams BR et al. Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro. Int J Nanomedicine 2006 1 : 155 162.
44. Jiang G, Park K, Kim J, Kim KS, Oh EJ, Kang H et al. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers 2008 89 : 635 642.
45. Swami A, Kurupati RK, Pathak A, Singh Y, Kumar P, Gupta KC. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Biochem Biophys Res Commun 2007 362 : 835 841.
46. Lee SH, Choi SH, Kim SH, Park TG. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J Control Release 2008 125 : 25 32.
47. Hoon Jeong J, Christensen LV, Yockman JW, Zhong Z, Engbersen JF, Jong Kim W et al. Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 2007 28 : 1912 1917.
48. Liu X, Howard KA, Dong M, Andersen MO, Rahbek UL, Johnsen MG et al. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007 28 : 1280 1288.
49. Ghosn B, Kasturi SP, Roy K. Enhancing polysaccharide-mediated delivery of nucleic acids through functionalization with secondary and tertiary amines. Curr Top Med Chem 2008 8 : 331 340.
50. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A 2007 104 : 15549 15554.
51. Shen XC, Zhou J, Liu X, Wu J, Qu F, Zhang ZL et al. Importance of size-to-charge ratio in construction of stable and uniform nanoscale RNA/dendrimer complexes. Org Biomol Chem 2007 5 : 3674 3681.
52. Zhou J, Wu J, Hafdi N, Behr JP, Erbacher P, Peng L. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun (Cambridge, England) 2006 22 : 2362 2364.
53. Oliveira S, van Rooy I, Kranenburg O, Storm G, Schiffelers RM. Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes. Int J Pharm 2007 331 : 211 214.
54. Fattal E, Bochot A. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv Drug Deliv Rev 2006 58 : 1203 1223. (Pubitemid 44778909)
55. Massaro D, Massaro GD, Clerch LB. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice. Am J Physiol Lung Cell Mol Physiol 2004 287 : L1066 70.
56. Bitko V, Barik S. Nasal delivery of siRNA. Methods Mol Biol 2008 442 : 75 82.
57. Yoshizawa T, Hattori Y, Hakoshima M, Koga K, Maitani Y. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur J Pharm Biopharm 2008 70 : 718 725.
58. Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada H. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Control Release 2008 126 : 246 254.
59. Xiao H, Wu Z, Shen H, Luo AL, Yang YF, Li XB et al. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi. Basic Clin Pharmacol Toxicol 2008 103 : 342 348.
60. Zhang Y, Cristofaro P, Silbermann R, Pusch O, Boden D, Konkin T et al. Engineering mucosal RNA interference in vivo. Mol Ther 2006 14 : 336 342.
61. Sepp-Lorenzino L, Ruddy M. Challenges and opportunities for local and systemic delivery of siRNA and antisense oligonucleotides. Clin Pharmacol Ther 2008 84 : 628 632.
62. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009 8 : 129 138.
63. Cesarone G, Edupuganti OP, Chen CP, Wickstrom E. Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem 2007 18 : 1831 1840.
64. Oishi M, Nagasaki Y, Itaka K, Nishiyama N, Kataoka K. Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc 2005 127 : 1624 1625.
65. Kim SH, Mok H, Jeong JH, Kim SW, Park TG. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjug Chem 2006 17 : 241 244.
66. Li SD, Chono S, Huang L. Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. J Control Release 2008 126 : 77 84.
67. Rozema DB, Lewis DL, Wakefield DH, Wong SC, Klein JJ, Roesch PL et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci U S A 2007 104 : 12982 12987.
68. Schiffelers RM, Ansari A, Xu J, Zhou Q, Tang Q, Storm G et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 2004 32 : e149.
69. de Wolf HK, Snel CJ, Verbaan FJ, Schiffelers RM, Hennink WE, Storm G. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. Int J Pharm 2007 331 : 167 175.
70. Watanabe T, Umehara T, Yasui F, Nakagawa S, Yano J, Ohgi T et al. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. J Hepatol 2007 47 : 744 750.
71. Sato A, Takagi M, Shimamoto A, Kawakami S, Hashida M. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice. Biomaterials 2007 28 : 1434 1442.
72. Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target. Science 2008 319 : 627 630.
73. Pirollo KF, Zon G, Rait A, Zhou Q, Yu W, Hogrefe R et al. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther 2006 17 : 117 124.
74. Xia CF, Zhang Y, Zhang Y, Boado RJ, Pardridge WM. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology. Pharm Res 2007 24 : 2309 2316.
75. Hogrefe RI, Lebedev AV, Zon G, Pirollo KF, Rait A, Zhou Q et al. Chemically modified short interfering hybrids (siHYBRIDS): nanoimmunoliposome delivery in vitro and in vivo for RNAi of HER-2. Nucleosides Nucleotides Nucleic Acids 2006 25 : 889 907.